Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

"Priority" Review Slow Down: The Prasugrel Delay

Oct 01 2008

• By Ramsey Baghdadi

Related Content

The FDA Roundtable Part I: The Regulators' View of Drug Development

Sep 01 2008

Prasugrel Could Avoid More Restrictive REMS Options, Lilly Hints

Jul 28 2008

The New User Fee Rules: FDA Sacrifices Timeliness, Tries to Save Predictability

Mar 01 2008

Related Companies

Eli Lilly and Company

Pfizer Inc.

H. Lundbeck A/S

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window